Clinical Decision Support for Atrial Fibrillation and Flutter
- Conditions
- Atrial Fibrillation and Flutter
- Registration Number
- NCT05009225
- Lead Sponsor
- Kaiser Permanente
- Brief Summary
Atrial fibrillation (AF) is a major public health problem: it impairs quality of life and independently heightens the risks of ischemic stroke, heart failure and all-cause mortality. AF is a common reason for presenting to emergency departments (ED) in Kaiser Permanente Northern California (KPNC) and is associated with frequent hospitalization. Additionally, inter-facility hospitalization rates for AF vary across KPNC. Improvements in modifiable components of ED AF care could potentially reduce low-yield hospitalizations and the associated costs, patient inconveniences, and complications that can ensue. Real-time clinical decision support systems (CDSS) can transform entrenched physician practices and improve patient outcomes. The investigators will conduct a stepped-wedge cluster randomized trial of a CDSS intervention across 13 KPNC EDs for the comprehensive management of acute AF with the following three aims: 1) To evaluate the impact of the CDSS intervention on index hospitalization rates; 2) To evaluate the impact of the CDSS intervention on ED AF rate and rhythm control process-of-care metrics; and 3) To evaluate the impact of the CDSS intervention on AF stroke prevention actions for eligible participants at the time of ED discharge. The investigators hypothesize that the CDSS intervention will safely reduce index hospitalization rates, improve rate and rhythm control process-of-care metrics, and increase stroke prevention actions for eligible participants at ED discharge and within 30 days.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 4000
- Adult (≥18y) KPNC members presenting to the ED with a primary ED diagnosis of atrial fibrillation/flutter (AF/FL). Subjects who meet criteria will be identified electronically within the CDSS tool in the electronic health record.
- Children (<18y).
- Non-members of KPNC.
- Patients who were prisoners, pregnant, receiving hospice or palliative care, or who left against medical advice at the index encounter for AF/FL.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who received sustained rate-reduction medications Through emergency department visit, an average of 8 hours Number of patients who were hospitalized Through emergency department visit, an average of 8 hours Number of patients who received stroke prevention interventions Through emergency department visit, an average of 8 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (16)
Kaiser Permanente Antioch Emergency Department
🇺🇸Antioch, California, United States
Kaiser Permanente Fremont Emergency Department
🇺🇸Fremont, California, United States
Kaiser Permanente Manteca Medical Center
🇺🇸Manteca, California, United States
Kaiser Permanente Modesto Medical Center
🇺🇸Modesto, California, United States
Kaiser Permanente Oakland Emergency Department
🇺🇸Oakland, California, United States
Kaiser Permanente Richmond Emergency Department
🇺🇸Richmond, California, United States
Kaiser Permanente Roseville Emergency Department
🇺🇸Roseville, California, United States
Kaiser Permanente South Sacramento Emergency Department
🇺🇸Sacramento, California, United States
Kaiser Permanente Sacramento Emergency Department
🇺🇸Sacramento, California, United States
Kaiser Permanente San Francisco Emergency Department
🇺🇸San Francisco, California, United States
Scroll for more (6 remaining)Kaiser Permanente Antioch Emergency Department🇺🇸Antioch, California, United States